Airgas USA, LLC
Form 483 issued March 12, 2021 · Ventura, California
- Inspection
- Mar 8 – Mar 12, 2021
- Investigator
- Kouros Kangarli
- Observations
- 1
- Pages
- 3
- FEI number
- 2027660
In short: On March 12, 2021, FDA issued a Form 483 with 1 observation to Airgas USA, LLC in Ventura, California (FEI 2027660) after an inspection that ran Mar 8 – Mar 12, 2021. The investigator was Kouros Kangarli. Most observations concern production; the most-cited regulation is 21 CFR 211.100 (written procedures; deviations).
At a glance
1 of 1 observations on this 483 concern production.
Most cited: 21 CFR 211.100(b) (1×)
What FDA observed
Preview: the opening words of each observation- 01
Written production and process control procedures are not followed in the execution of production…
This inspection in context
Kouros Kangarli
3 documents · 2019–2021
Cites 211.100(a) (written procedures; deviations) more than any other section. Most of their documents are for sites in California.
The firmAirgas USA, LLC history
The site's inspection history, in date order.
Similar 483sOther sites cited under 211.100(b)
See how FDA wrote the same problem up elsewhere.
Questions about this 483
What did FDA find at Airgas USA, LLC?
FDA listed 1 observation on this Form 483, mostly about production. The most-cited regulation is 21 CFR 211.100 (written procedures; deviations). The opening words of each observation are shown on this page.
Who inspected Airgas USA, LLC?
Kouros Kangarli is named on this Form 483, for the inspection of Mar 8 – Mar 12, 2021. Each investigator has a profile showing what they cite most.
When was Airgas USA, LLC inspected by FDA?
The inspection ran Mar 8 – Mar 12, 2021, and the Form 483 is dated March 12, 2021.
How do I get the full Form 483 for Airgas USA, LLC?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.